Jack Nathan Health Signs Letter of Intent

TORONTO -- Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) (the “Company”) announces that, further to recent Company press releases reporting that the Company will be exploring certain strategic alternatives (see the Company’s August 13, 2024 and August 7, 2024 press releases), the Company has entered into a non-binding letter of intent (the “LOI”) for a proposed transaction. The proposed transaction is subject to, among other things, the negotiation and execution of a definitive agreement (the “Definitive Agreement”) and the completion of satisfactory due diligence by the other party to the LOI. In connection with the execution of the LOI, the Company agreed to a 30-day exclusivity period with the other party and has secured conditional funding to support the Company’s cash flow requirements while the parties work towards negotiating and entering into the Definitive Agreement. The LOI does not create any legally binding obligations to enter into a Definitive Agreement, and no assurance can be provided that a Definitive Agreement will be signed. If a Definitive Agreement is signed, transaction details will be provided by the Company at that time. Read More